Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In cortisone reductase deficiency (CRD), activation of cortisone to cortisol does not occur, resulting in adrenocorticotropin-mediated androgen excess and a phenotype resembling polycystic ovary syndrome (PCOS; refs. 1,2). This suggests a defect in the gene HSD11B1 encoding 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a primary regulator of tissue-specific glucocorticoid bioavailability. We identified intronic mutations in HSD11B1 that resulted in reduced gene transcription in three individuals with CRD. In vivo, 11beta-HSD1 catalyzes the reduction of cortisone to cortisol whereas purified enzyme acts as a dehydrogenase converting cortisol to cortisone. Oxo-reductase activity can be regained using a NADPH-regeneration system and the cytosolic enzyme glucose-6-phosphate dehydrogenase. But the catalytic domain of 11beta-HSD1 faces into the lumen of the endoplasmic reticulum (ER; ref. 6). We hypothesized that endolumenal hexose-6-phosphate dehydrogenase (H6PDH) regenerates NADPH in the ER, thereby influencing directionality of 11beta-HSD1 activity. Mutations in exon 5 of H6PD in individuals with CRD attenuated or abolished H6PDH activity. These individuals have mutations in both HSD11B1 and H6PD in a triallelic digenic model of inheritance, resulting in low 11beta-HSD1 expression and ER NADPH generation with loss of 11beta-HSD1 oxo-reductase activity. CRD defines a new ER-specific redox potential and establishes H6PDH as a potential factor in the pathogenesis of PCO…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This disorder is caused by inactivating mutations in H6PDH (590), which impair NADPH regeneration within the endoplasmic reticulum, rather than by mutations in the coding regions of HSD11B1.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [590]
In the citing paper
“Elevated anti-Müllerian hormone (AMH) levels have been a consistent hormonal finding associated with PCOM in healthy girls [90,91]”
From The Diagnosis of Polycystic Ovary Syndrome during Adolescence (2015) · cites this paper as [91]
In the citing paper
“Cortisone reductase deficiency (CRD) and apparent CRD (ACRD) are characterised by the failure to generate cortisol from inactive cortisone resulting in HPA axis activation and excessive ACTH-mediated adrenal androgen secretion, with ∼14 cases described clinically and biochemically in the literature (1, 2, 3, 4, 5, 6, 7, 8, 9) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [2]
In the citing paper
“CRD is caused by HSD11B1 deficiency (90) whereas ACRD results form a deficiency in the activity of H6PDH, which is essential for maintaining the reductive activity of HSD11B1 in vivo by the reduced form of NAD phosphate provision to the enzyme (91, 92).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [91]
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“) and adipose tissue (increased adipocyte differentiation and visceral obesit”
BackgroundCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationGlucose-6-phosphate Dehydrogenase
Löhr, G. W., & Waller, H. D. (1974) · Methods of Enzymatic Analysis · doi:10.1016/b978-0-12-091302-2.50026-8 · Cited by 1,190
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Digenic Retinitis Pigmentosa Due to Mutations at the Unlinked Peripherin/ RDS and ROM1 Loci
Kajiwara, K., Berson, E. L., & Dryja, T. P. (1994) · Science · doi:10.1126/science.8202715 · Cited by 775
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationTriallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder
Katsanis, N., Ansley, S. J., Badano, J. L., Eichers, E. R., Lewis, R. A., Hoskins, B. E., Scambler, P. J., Davidson, W. S., Beales, P. L., & Lupski, J. R. (2001) · Science · doi:10.1126/science.1063525 · Cited by 655 · cited 1×
“To our knowledge, however, there are only a few documented examples of a digenic triallelic trait: Bardet–Biedl syndrome, a heterogeneous disorder with symptoms including mental retardation, pigmentary retinopathy and obesit”
BackgroundKletzien, R. F., Harris, P. K. W., & Foellmi, L. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119488 · Cited by 550
Cited by
Items 201–288 of 288
Jonas, K., Chandras, C., Abayasekara, D. R. E., & Michael, A. E. (2006) · Endocrinology · doi:10.1210/en.2006-0723 · Cited by 15
Szappanos, Á., Patócs, A., Gergics, P., Bertalan, R. Á., Kerti, A., Ács, B., Feldman, K., Rácz, K., & Tóth, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.009 · Cited by 14
Qin, K., & Rosenfield, R. L. (2010) · Steroids · doi:10.1016/j.steroids.2010.10.001 · Cited by 13
“patients [18–20], although it was initially suspected of doing so [22].”
BackgroundWang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Lutfy, K., Friedman, T. C., Jiang, M., & Liu, Y. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2013 · Cited by 15
“Targeted deletion or mutation of H6PDH results in a switch in set-point of 11ß-HSD1 inactivating cortisol to cortisone and demonstrated the physiologically relevant of 11ß-HSD1 for H6PDH (6, 14).”
BackgroundDoig, C. L., Zielinska, A. E., Fletcher, R. S., Oakey, L. A., Elhassan, Y., Garten, A., Cartwright, D., Heising, S., Alsheri, A., Watson, D. G., et al. (2020) · Skeletal Muscle · doi:10.1186/s13395-019-0216-z · Cited by 13
“(ACRD) due to inactivating mutations in the H6pd gene [8, 9].”
BackgroundSelf-citationSoulier, A., Blois, S. M., Sivakumaran, S., Fallah‐Arani, F., Henderson, S. R., Flutter, B. R., Rabbitt, E. H., Stewart, P. M., Lavery, G. G., Bennett, C. L., et al. (2013) · Blood · doi:10.1182/blood-2013-03-489138 · Cited by 12
Self-citationAl‐Agha, A., Ah, O., & Al-Tamimi (2012) · PubMed · Cited by 17
Nonneoplastic Lesions of the Ovary
Irving, J. A., & Clement, P. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0489-8_12 · Cited by 14
Pierre, K. K., Schlesinger, N., & Androulakis, I. P. (2017) · Journal of Biological Rhythms · doi:10.1177/0748730417729929 · Cited by 14
Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis
Alcina, A., Ramagopalan, S. V., Fernández, Ó., Catalá-Rabasa, A., Fedetz, M., Ndagire, D., Leyva, L., Arnal, C., Delgado, C., Lucas, M., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.213 · Cited by 13
Auchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Le syndrome des ovaires polykystiques (SOPK)
Torre, A., & Fernandez, H. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.04.002 · Cited by 22
Robinson, J. F., & Katsanis, N. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_8 · Cited by 14
Moreira, R. P. P., Bachega, T. A. S. S., Machado, M. C., Mendonca, B. B., Bronstein, M. D., & Fragoso, M. C. B. V. (2013) · Clinics · doi:10.6061/clinics/2013(05)01 · Cited by 12
11β-hydroxystéroïde déshydrogénases. Avancées récentes
Vantyghem, M., Marcelli-Tourvieille, S., Defrance, F., & Wémeau, J.-L. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.02.003 · Cited by 13
Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment
Viapiana, O., Gatti, D., Troplini, S., Adami, S., Fracassi, E., Idolazzi, L., & Rossini, M. (2014) · Rheumatology International · doi:10.1007/s00296-014-3105-0 · Cited by 10
Wang, H., Zhu, Y., Li, M., Pan, J., Li, D., Guo, W., Xie, G., & Du, L. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1208538 · Cited by 10
“org hexose-6-phosphate dehydrogenase activity and catalyzes the first step of the pentose phosphate pathway (27, 28).”
BackgroundLi, C., Liu, T., Wang, J., Yu, S.-C., Chen, Y., Fang, F., Li, W., & Huang, H. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110408 · Cited by 10
“In patients with cortisone-reductase deficiency, the mutations in HSD11B1 or hexose-6-phosphate dehydrogenase (H6PD) that encodes an enzyme furnishing cofactors for the reaction might abrogate cortisol generation and consequently stimulate adrenal hyperandrogenism mediated by adrenocorticotropic hormone [25,26].”
BackgroundStørkson, R. H., Aamodt, R., Vetvik, K. K., Pietiläinen, K. H., Bukholm, G., Jónsdóttir, K., Vollan, H. S., Sonerud, T., Lüders, T., Jacobsen, M., et al. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1442-6 · Cited by 12
Devang, N., Satyamoorthy, K., Rai, P. S., Nandini, M., Basu, A., & Adhikari, P. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0596-8 · Cited by 9
“sg/) taking into account the HSD11B1 rs12086634 G allele frequency of 35 and 14%, respectively, in the case and control Caucasian population [9].”
BackgroundBloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1227 · Cited by 11
Expanding the Autosomal Recessive Gene Spectrum of Parkinson's Disease: A Study within the CPD10KGP
Zhao, Y., Pan, H., Wang, Y., Chen, J., Guan, H., Ren, Z., Zhou, X., Xiang, Y., Wu, H., Tan, J., et al. (2025) · Movement Disorders · doi:10.1002/mds.70039 · Cited by 8
A genome-wide association study of antidepressant-induced mania
Zai, C. C. H., Squassina, A., Tiwari, A. K., Pisanu, C., Pinna, M., Pinna, F., Meloni, A., Paribello, P., Carpiniello, B., Tondo, L., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110800 · Cited by 8
Zhu, Q., Dong, Y., Li, X., Ni, C., Huang, T., Sun, J., & Ge, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00886 · Cited by 8
Glucocorticoid Receptor in Health and Disease
Dundjerski, J., & Matić, G. M. (2009) · Journal of Medical Biochemistry · doi:10.2478/v10011-009-0022-y · Cited by 8
Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome
Grolmusz, V. K., Ács, O. D., Feldman, K., Szappanos, Á., Stenczer, B., Fekete, T., Szendei, G., Reismann, P., Rácz, K., & Patócs, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3473-2 · Cited by 8
Ju, R., Wu, W., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140326 · Cited by 7
“HSD11B1 located at chromosome lq32-41 responsible for the regeneration of glucocorticoids from hormonally-inactive metabolites into active forms in a tissue-specific manner [17].”
BackgroundLiu, L., Wang, Y., Wang, J., Dong, Y., Chang, S., Liu, X., Lutfy, K., Chen, H., Friedman, T. C., Jiang, M., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0041-1 · Cited by 7
Lin, L., & Achermann, J. C. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080495 · Cited by 15
Fichna, M., Żurawek, M., Gryczyńska, M., Sowińska, A., Nowak, J., & Ruchała, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.03.027 · Cited by 7
Pharmacogenomics of Osteoporosis
Gennari, L. (2010) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-010-9071-5 · Cited by 7
“Other allelic variants in different genes such as the 11betahydroxysteroid dehydrogenase type 1 (HSD11B1) and the hexose-6-phosphate dehydrogenase (H6PD) genes may affect the disposition and activity of glucocorticoids in target tissues [ 124 ].”
BackgroundA missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia
Jacobs, J., Lyubenova, H., Potelle, S., Kopp, J., Gerin, I., Chan, W. L., Santos, M. R. D. L., Hülsemann, W., Mensah, M. A., Cormier‐Daire, V., et al. (2025) · Nature · doi:10.1038/s41586-025-09397-x · Cited by 7
“To date, H6PD has primarily been recognized for its role in maintaining a low NADP + /NADPH ratio within the endoplasmic reticulum, a requirement for 11β-hydroxysteroid dehydrogenase type 1 to convert cortisone into its biologically active form, cortisol 36,37 .”
SEXUAL PRECOCITY: A HISTORICAL PERSPECTIVE AND UPDATE
Root, A. W. (2005) · Fetal and Pediatric Pathology · doi:10.1080/15227950590961207 · Cited by 5
“Deficiency of cortisone reductase, an enzyme complex that converts cortisone to cortisol, also leads to impaired cortisol synthesis and then to increased ACTHresponsive adrenal androgen synthesis that leads to isosexual precocity in boys [38, 39].”
BackgroundCabrera-Sharp, V., Mirczuk, S. M., Shervill, E., Michael, A. E., & Fowkes, R. C. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1613-y · Cited by 5
Nonneoplastic Lesions of the Ovary
Irving, J. A., & Clement, P. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_12 · Cited by 7
Synergistic Effects of Ageing and Stress on Neutrophil Function
Lord, J. M., Phillips, A. C., & Arlt, W. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_24 · Cited by 6
Self-citationIdentification of SNPs, or Mutations in Sequence Chromatograms
Draper, N. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-188-8_3 · Cited by 4
Self-citationThiazolopyridines Improve Adipocyte Function by Inhibiting 11 Beta-HSD1 Oxoreductase Activity
Thirumurugan, R., Jackson, K. M. P., Thor, Y., Buru, A. S., Esposito, D., Li, X., Pichika, M. R., Hamzah, A. S., & Komarnytsky, S. (2017) · Journal of Chemistry · doi:10.1155/2017/3182129 · Cited by 5
Ligand Regulation and Nuclear Receptor Action
Hewison, M. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_16 · Cited by 5
Self-citationPhysiologie et exploration des sécrétions de cortisol et d'androgènes par la surrénale
Oudet, B., Rigabert, J., Young, J., & Raffin‐Sanson, M. (2010) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(10)43047-4 · Cited by 8
11β-Hydroxysteroid Dehydrogenases in the Regulation of Tissue Glucocorticoid Availability
Pereira, C., Monteiro, R., Constância, M., & João, M. (2012) · InTech eBooks · doi:10.5772/53645 · Cited by 3
“This be‐ comes evident when 11β-HSD1 switches from a dehydrogenase to a reductase functioning in human omental adipose stromal cells upon differentiation (Bujalska et al., 2002a; Bujalska et al., 2002b) or when it acts mainly as a dehydrogenase in the liver or AT of the H6PDH null mouse (Bujalska et al., 2008; Lavery…”
BackgroundInfluentialFürst‐Recktenwald, S., Dörr, H. G., Quinkler, M. O., Dötsch, J., & Stewart, P. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04406.x · Cited by 3
Self-citationGlucocorticoid Metabolism and Activation
Othonos, N., & Tomlinson, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64302-7 · Cited by 4
Self-citationTowards a Virtual Research Environment for Paediatric Endocrinology across Europe
Jiang, J., Sinnott, R., Stell, A., Watt, J., & Ahmed, S. F. (2009) · IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing (CCGrid) · doi:10.1109/ccgrid.2009.68 · Cited by 2
11β-Hydroxysteroid Dehydrogenase Type 1 and the Metabolic Syndrome
Cidalia, D., Maria, J., Azevedo, I., & Monteiro, R. (2011) · InTech eBooks · doi:10.5772/28641 · Cited by 2
“In the H6PDH null mouse, hepatic or AT, 11┚-HSD1 acts mainly as a dehydrogenase (Bujalska et al., 2008b; Lavery et al., 2006).”
BackgroundInfluentialSequence and expression of 11β-hydroxysteroid dehydrogenase type 1 cDNA cloned from pig testis
Ohno, S., Ohta, M., Honda, Y., & Nakajin, S. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0348-2 · Cited by 2
Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
Sbardella, E., & Tomlinson, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_14 · Cited by 3
Self-citationArmanini, D., Pellati, D., & Fiore, C. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093690 · Cited by 2
Are There Patients with Inflammatory Disease Who Do Not Respond to Prednisone?
Sen, D., Rajbhandary, R., Carlino, A., Anderson, R. J., Schur, P. H., & Panush, R. S. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091260 · Cited by 2
Glucose Intolerance in Polycystic Ovary Syndrome: Focus on the β-Cell
Ehrmann, D. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_20 · Cited by 1
Targeting 11β-hydroxysteroid dehydrogenase type 1 in brain: therapy for cognitive aging?
Yau, J. L. W., MacLullich, A. M. J., & Seckl, J. R. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.4.527 · Cited by 2
Genetic Considerations in the Evaluation of Menstrual Cycle Irregularities
Abusag, M., Ehrmann, D. A., & Hoffman, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00018-x · Cited by 1
Naseri, R., Alimoradi, Y., Sohrabi, M., Fard, M. C., Barzingarosi, E., Abdolmaleki, A., & Jalili, C. (2022) · PubMed Central · doi:10.22074/ijfs.2021.141690.1050 · Cited by 1
“CRD is seen in hyperandrogenic signs, including oligo-amenorrhea, hirsutism, and female infertility, as well as premature puberty in males (9).”
Background11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Stimson, R. H., & Walker, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_10 · Cited by 1
Bánhegyi, G., Benedetti, A., & Csala, M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb152 · Cited by 1
Sunak, N. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Corticosteroid hormone action in the cardiovascular system
Hammer, F. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Análisis de polimorfismos de genes asociados al síndrome metabólico en niños obesos
Olza, J. (2011) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
Genetic Considerations in the Evaluation of Menstrual Cycle Irregularities
Hoffman, L., & Ehrmann, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00019-5
Velásquez, N. (2011) · Revista de Obstetricia y Ginecología de Venezuela · Cited by 8
11beta-hydroxysteroid dehydrogenase type 1 as a pharmacological target in metabolic disease
Hult, M. (2004) · Figshare
Glucocorticoids, 11-β hydroxysteroid dehydrogenase and glucose metabolism
Stewart, P. M. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95637-5
Self-citationGenetic determinants of antipsychotic drug response
Gregoor, J. G. (2012) · Utrecht University Repository (Utrecht University)
Glucocorticoid sensitivity: pathology, mutations and clinical implications
Ray, D. W., Donn, R. P., & Berry, A. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.3.403 · Cited by 1
Self-citationBos, P. (2010) · Nottingham ePrints (University of Nottingham)
Tissue Metabolism of Glucocorticoids: New Controls of Cognitive Function and the Stress Response
Seckl, J. R. (2007) · Springer eBooks · doi:10.1007/4-431-29567-4_11
Title of dissertation: HIGH SUCROSE, FRUCTOSE, AND GLUCOSE DIETS AND GLUCOCORTICOID DYSREGULATION IN
London, E., & Castonguay, T. W. (2009)
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Marina, P., & Beirut, L. (2016)
The Syndrome of Apparent Mineralocorticoid Excess
White, P. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00017-6 · Cited by 1
Self-citationKandasamy, M., SALIHIN, M., Pichika, M. R., Komarnytsky, S., & Thirumurugan, R. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.3.p120-130
Voisin, M. (2015) · theses.fr (ABES) · doi:10.70675/831e14f7z0b33z4793z8846z6f418c71453e · Cited by 1
Nonneoplastic Lesions of the Ovary
Irving, J. A., & Clement, P. B. (2018) · Springer eBooks · doi:10.1007/978-1-4614-3165-7_12-2
Disorders of Adrenals and Gonads
Biason‐Lauber, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_55
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00019-x
Shah, Z. A., & Tayyab, A. (2024) · Albus Scientia · doi:10.56512/as.2024.1.e240522
“…convert into cortisol, upregulates ACTH expression and leads to androgen synthesis under 11β-HSD type I deficiency (Moghetti et al., 2013; Lizneva et al., 2016; Celik et al., 2016; Rosenfield & Ehrmann, 2016; Ashraf et al., 2019; Goodarzi et al., 2015; Louwers et al., 2013; Draper et al., 2003).”
BackgroundGlucocorticoid metabolism and activation
Othonos, N., & Tomlinson, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00210-7
Self-citationSequenciação dos genes G6PD e H6PD: implementação e implicações na COVID-19.
Esgueirão, J. O. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Multicellular regulation of the pancreatic islet in diabetes
Fine, N. H. F. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham)
Fu, J. Q., Wang, H., Yan, J., Chen, W., Wang, R., Gao, H., & Li, C. (2026) · Biomolecules · doi:10.3390/biom16030468
“Studies have revealed that H6PD is an essential component of the intracellular glucocorticoid-activated system and participates in the pathological processes of insulin resistance and metabolic syndrome [60,61].”
Variabilité phénotypique et épissage : combinaison d'analyses in vitro et in silico du gène CFTR
Aissat, A. (2012) · theses.fr (ABES) · doi:10.70675/5b1bcfaez5daaz41c0z8af2zbd48e8dfc67b
Zhao, C., Yu, Z., Wang, M., Ying, Y., Tang, Y., Li, H., Ge, R., & Liang, J. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117883
Madsen, M. R., Ali, D., Palmier, M., Caci, A., Akimov, V., Haakonsson, A. K., Blagoev, B., Kassem, M. S., Mandrup, S., & Rauch, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.18.752640
“GC resistance caused by mutations in NR3C1 (Kino et al., 2000), or impaired cortisol regeneration resulting from mutations in HSD11B1 and H6PD (Draper et al., 2003; Lavery et al., 2008; Lawson et al., 2011), are accompanied by compensatory endocrine adaptations and lack a consistent skeletal…”
BindingDB (2010) · UC San Diego · doi:10.7270/q2ww7hvq
BindingDB (2013) · UC San Diego · doi:10.7270/q25b03tm
Lo screening delle malattie genetiche del surrene
Giraldi, F. P. (2006) · L Endocrinologo · doi:10.1007/bf03345946
Metadata
- Authors
- Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., Malunowicz, E., White, P. C., Hewison, M., Mason, P. J., Connell, J. M., Shackleton, C. H. L., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- The University of Texas Southwestern Medical Center (US)
- Hammersmith Hospital (GB)
- University of Glasgow (GB)
- UCSF Benioff Children's Hospital (US)
- Corresponding author
- Stewart, Paul M
- ORCID
- Venue
- Nature Genetics
- Published
- 2003-07-13
- Volume
- 34
- Issue
- 4
- Pages
- 434-439
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2104167472
- Semantic Scholar
- cfd40673c0802069d07c6edccb428ba58392c928
- Cited by
- 285
- References
- 33
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 5 · 2014: 12 · 2013: 14 · 2012: 22
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- University Hospitals Birmingham NHS Foundation Trust
- University of Birmingham
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, hexose-6-phosphate dehydrogenase, intronic variants, NADPH regeneration, endoplasmic reticulum, glucocorticoid metabolism, ACTH, hyperandrogenism, polycystic ovary syndrome, digenic inheritance, gene transcription
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carbohydrate Dehydrogenases, Cell Line, Cortisone Reductase, Endoplasmic Reticulum, Exons, Female, Humans, Hydroxysteroid Dehydrogenases, Male, Molecular Sequence Data, Mutation, NADP, Oxidation-Reduction, Phenotype, Polycystic Ovary Syndrome, RNA, Messenger, Transfection, Case-Control Studies, Sequence Homology, Amino Acid, DNA, Complementary, 11-beta-Hydroxysteroid Dehydrogenase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.